HSBC analyst warns of a downside in Eli Lilly stock to $700. Rajesh Kumar cited 'valuation' as his number 1 concern.

Novo Nordisk (NVO) has launched its weight-loss drug Wegovy in Thailand, Reuters reported on Monday, citing an executive of ...

The Trump administration this month scrapped a Biden-era proposal that would have required state Medicaid programs and ...

Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company for cardiometabolic diseases and GI oncological indications announced today that it ...

The weight-loss drugs have grown in popularity, but are generally too expensive for most people to afford without insurance ...

A PRESENTER has candidly opened up on her “absolutely horrendous” experience while using Mounjaro. Danielle Mason, an ...

Weight loss injections can be useful aids for people who are struggling to shed unwanted pounds. GLP-1 agonist jabs, like ...

President Donald Trump is under pressure to decide how widely available anti-obesity drugs should be and whether Medicare should cover them.

Novo Nordisk remains financially strong, but pricing pressures and CagriSema challenges limit near-term upside. Find out why ...

This week in Ozempic news: No more compounded GLP-1s, weight-loss pills are coming, and WeightWatchers is filing for ...

The Lessie B. Price Center advertised their fitness programs for seniors and educational programs for youth at their open ...

The Columbia County Spring Fair is back in town, but this time with some policy changes amid disruptions last week.